{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "12966720", "DateCompleted": {"Year": "2003", "Month": "12", "Day": "18"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "20"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0869-8139", "JournalIssue": {"Volume": "89", "Issue": "4", "PubDate": {"Year": "2003", "Month": "Apr"}}, "Title": "Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova", "ISOAbbreviation": "Ross Fiziol Zh Im I M Sechenova"}, "ArticleTitle": "[Effect of ozone exposure on contractile activity and chemoreactivity of uterus horns longitudinal muscles of nonpregnant rats].", "Pagination": {"StartPage": "427", "EndPage": "435", "MedlinePgn": "427-35"}, "Abstract": {"AbstractText": ["With the purpose of studying the mechanism of ozone action on uterus smooth muscles it was investigated the influence of ozone-content (approximately 0.50 mkg/ml) Krebs' solution or its 10- and 100-fold dissolution on contractile activity and beta-adrenoreactivity of 56 longitudinal strips of uterus horns of 17 nonpregnant rats. Ozone at concentration approximately 0.50 mkg/ml (but not in concentration of approximately 0.05 and approximately 0.005 mkg/ml) reversibly raised frequency, amplitude and total contractile activity of intact myometrium strips, and also fast and reversibly reducel its beta-adrenoreactivity, i.e. decreased of inhibitory action of adrenaline (10(-8), 10(-7), 10(-6) g/ml), but did not change uterostimulatory effect of acetylcholine (10(-6) g/ml) and oxiyocin (5 x 10(-4) ME/ml), what evident about specificity of ozone beta-adrenoblokate effect. Ozone (approximately 0.50 and 0.05 mkg/ml) did not change ov value of potassium contracture of myometrium strips which was depolarized by hyperpotassium (60 mM KCL) Krebs' solution, but reduced inhibitory action of adrenaline (10(-8) g/ml). The question is being discussed about mechanisms of ozone beta-adrenoblocade actions, about clinical role of this phenomenon, and the possibility of using beta-adrenoreceptor sensibilizators direct action (histidine, tryptophan, tyrosine, trimetazidin and mildronat) at ozonotherapy with the purpose reduction of its negative effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Viatka State Humanitarian University, 111 Lenin St., 610002, Kirov, Russia."}], "Identifier": [], "LastName": "Sizova", "ForeName": "E N", "Initials": "EN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tsirkin", "ForeName": "V I", "Initials": "VI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kostiaev", "ForeName": "A A", "Initials": "AA"}], "PublicationTypeList": ["English Abstract", "Journal Article"], "VernacularTitle": "Vliianie ozona na sokratitel'nuiu aktivnost' i khemoreaktivnost' prodol'no\u012d muskulatury roga matki neberemennykh krys."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Ross Fiziol Zh Im I M Sechenova", "NlmUniqueID": "9715665", "ISSNLinking": "0869-8139"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Adrenergic Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Adrenergic, beta"}, {"RegistryNumber": "50-56-6", "NameOfSubstance": "Oxytocin"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}, {"RegistryNumber": "YKH834O4BH", "NameOfSubstance": "Epinephrine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Acetylcholine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Adrenergic Agonists"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Adrenergic Antagonists"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Epinephrine"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Muscle, Smooth"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxytocin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Adrenergic, beta"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Uterus"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "9", "Day": "12", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "12", "Day": "19", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "9", "Day": "12", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12966720"]}}], "PubmedBookArticle": []}